MD Financial Management’s Sempra SRE Stock Holding History

MD Financial Management’s Portfolio SRE Stock Details SRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$2.25M	Buy	33,936 +2,464	+8%	+$156K	0.05%	188
2021 Q3	$1.99M	Sell	31,472 -1,286	-4%	-$84.9K	0.05%	188
2021 Q2	$2.17M	Buy	+32,758	New	+$2.24M	0.06%	165

Other funds holding SRE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

MD Financial Management's SRE Position: Q4 2021 in Review

MD Financial Management increased its Sempra (SRE) stake by 7.8% in Q4 2021, buying an estimated $156K and bringing the position to 33,936 shares worth $2.25M. The position accounts for 0.05% of the portfolio, ranked #188.

MD Financial Management first reported a position in SRE in Q2 2021 and has held it in 3 quarters since. 885 funds tracked by Wall St. Rank hold SRE as of Q4 2021.

MD Financial Management held 33,936 shares of Sempra worth $2.25M as of Q4 2021.
MD Financial Management bought 2,464 Sempra shares in Q4 2021, an estimated $156K.
Sempra made up 0.05% of MD Financial Management's portfolio in Q4 2021, its #188 holding.
MD Financial Management first reported a position in Sempra in Q2 2021 and has held it in 3 quarters since.
885 funds tracked by Wall St. Rank held Sempra as of Q4 2021.

Based on MD Financial Management's 13F filing for Q4 2021, filed 14 Feb 2022.